Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
840.00    -10.00 (-1.18%)
Bid:
830.00
Ask:
850.00
Spread: 20.00 (2.41%)
Market Cap: £137.09m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

Hardman & Co: 2017: capital deployed, adding value

4 Apr 2018 11:15

RNS Number : 8029J
Arbuthnot Banking Group PLC
04 April 2018
 

Hardman & Co: 2017: capital deployed, adding value

2017: capital deployed, adding value: ABG has a long track record of adding value. The partial sale of its Secure Trust Bank (STB) in 2016 saw significant capital generated, and ABG is now deploying this surplus to generate returns. Despite heavy investment, profits nearly doubled, with loans and deposits up over a third. Credit remains outstanding, with the secured nature of lending seeing 2H'17 impairments of just £51k on a £1bn loan book. The outlook is for further strong profit growth, more investment, and greater diversification by business line and risk exposure. The shares trading below NAV appears an anomaly, given ABG's track record and earnings growth outlook.

http://hardmanandco.com/docs/default-source/company-docs/arbuthnot-banking-group-plc-documents/04.04.18-2017-capital-deployed-adding-value.pdf

To contact us:

Hardman & Co

35 New Broad Street

London

EC2M 1NH

Analysts:

Mark Thomas mt@hardmanandco.com

Telephone: +44 20 7194 7622

Follow us on Twitter @HardmanandCo

www.hardmanandco.com

About Hardman & Co: For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMMGGDGDFGRZM
Date   Source Headline
26th Jul 20181:50 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 1H'18 results: continuing the good work
17th Jul 20187:00 amRNSHalf Year Report
11th Jul 20187:00 amRNSAppointment of New Chief Executive Officer
10th May 20183:26 pmRNSAGM Statement
17th Apr 20183:23 pmRNSBoard Change
4th Apr 201811:15 amRNSHardman & Co: 2017: capital deployed, adding value
28th Mar 20187:00 amRNSFinal Results
22nd Feb 20187:00 amRNSPre close Trading Update
11th Oct 20177:00 amRNSArbuthnot Banking Group 3Q Trading Update
27th Jul 201711:35 amRNSHardman Research: Value added strategy in results
18th Jul 20177:00 amRNSHalf-year Report
4th May 20173:29 pmRNSAnnual General Meeting Statement - 2017
28th Apr 201711:20 amRNSCompletion of Acquisition
30th Mar 20175:03 pmRNSDirector/PDMR Shareholding
28th Mar 20171:29 pmRNSHardman Research: History is repeating itself
23rd Mar 20177:00 amRNSFinal Results for the year to 31 December 2016
21st Feb 20177:00 amRNSPre Close Trading Update
23rd Jan 20175:58 pmRNSDirector/PDMR Shareholding
23rd Jan 20173:27 pmRNSDirector/PDMR Shareholding
22nd Dec 201612:26 pmRNSHardman Research: Clear strategy, value added deal
20th Dec 20165:10 pmRNSAsset Backed Finance Acquisition
19th Dec 20167:00 amRNSLoan Portfolio Acquisition
9th Dec 201611:12 amRNSChange of Adviser
18th Oct 20169:36 amRNSHardman&Co. Special dividend, accelerated investm.
13th Oct 20167:00 amRNSThird Quarter Trading Update
6th Oct 20162:53 pmRNSAppointment of Independent Non-Executive Director
1st Aug 20163:22 pmRNSH&Co: Tripedalism - three legs are better than two
19th Jul 20167:00 amRNSResults for the six months to 30 June 2016
1st Jul 20164:40 pmRNSSecond Price Monitoring Extn
1st Jul 20164:35 pmRNSPrice Monitoring Extension
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
15th Jun 20165:36 pmRNSHolding(s) in Company
15th Jun 20165:22 pmRNSCompletion of sale by Arbuthnot Banking Group PLC
15th Jun 20165:16 pmRNSCompletion of sale
14th Jun 20165:06 pmRNSPhantom Share Option Scheme
14th Jun 201611:16 amRNSResults of General Meeting
10th Jun 20162:51 pmRNSAcqusition of West End Premises
10th Jun 201610:46 amRNSAnnouncement of New Independent NED
27th May 20164:30 pmRNSConditional sale of shares by Arbuthnot
27th May 20164:30 pmRNSConditional sale of shares in Secure Trust Bank
27th May 20167:00 amRNSProposed sale of ordinary shares in Secure Trust
27th May 20167:00 amRNSProposed sale by Arbuthnot of ordinary shares
5th May 20163:28 pmRNSAGM Statement
4th May 20163:20 pmRNSAGM Statement
14th Apr 20163:01 pmRNSBoard Changes
13th Apr 20163:47 pmRNSCompletion of the disposal of Everyday Loans Group
29th Mar 20163:58 pmRNSShare Purchase
21st Mar 20161:43 pmRNSShare Acquisition
17th Mar 20167:00 amRNSFinal Results for the year to 31 December 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.